Expanding Treatment Options for HER2+ Breast Cancer
June 30, 2020
Adam Brufsky, MD, PhD, UPMC Hillman Cancer CenterAdam Brufsky, MD, PhD, UPMC Hillman Cancer Center
Carey K. Anders, MD, Duke Cancer Institute
Virginia Kaklamani, MD, University of Texas Health Science Center
Rashmi K. Murthy, MD, MBE, MD Anderson Cancer Center
Mark D. Pegram, MD, Stanford Cancer Center
